References
- Schrijns VEJC. Mechanisms of vaccine adjuvant activity: initiation and regulation of immune responses by vaccine adjuvants. Vaccine21, 829–831 (2003).
- Medzhitov R, Preston-Hubert P, Janaway CA Jr. A human analogue of the Drosophila Toll protein signals activation of adaptive immunity. Nature388, 394–397 (1997).
- Akira S, Takeda K. Toll-like receptor signaling. Nature Rev. Immunol.4, 499–511 (2004).
- Van Eden W, Koets A, van Kooten P, Prakken B, van der Zee R. Immunopotentiating heat shock proteins: negotiators between innate danger and control of autoimmunity. Vaccine21(9–10), 897–901 (2003).
Websites
- CHMP Vaccine Expert Group, Guidelines on adjuvants in human vaccines. Recent regulations on the requirements for marketing authorization of adjuvants in new and novel vaccines www.emea.eu.int/pdfs/human/veg/001703en.pdf (Accessed January, 2005)
- World Health Organization www.who.int/en/ (Accessed January, 2005)
- European Medicines Agency www.emea.eu.int/ (Accessed January, 2005)
- www.meetingsmanagement.com/imv_2005 (Accessed January, 2005)